STRYKER CORP Effective Income Tax Rate Reconciliation, Tax Settlement, Amount
STRYKER CORP (SYK) reported Effective Income Tax Rate Reconciliation, Tax Settlement, Amount of $162.00 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-12.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationTaxSettlements · last filed 2025-02-12
- STRYKER CORP effective income tax rate reconciliation, tax settlement, amount for the quarter ending 2022-12-31 was $324.00M.
- STRYKER CORP effective income tax rate reconciliation, tax settlement, amount for the quarter ending 2022-09-30 was -$162.00M.
- STRYKER CORP effective income tax rate reconciliation, tax settlement, amount for fiscal 2024 was $162.00M, a 0.00% change from fiscal 2023.
- STRYKER CORP effective income tax rate reconciliation, tax settlement, amount for fiscal 2023 was $162.00M, a 0.00% change from fiscal 2022.
- STRYKER CORP effective income tax rate reconciliation, tax settlement, amount for fiscal 2022 was $162.00M.
| Period end | Effective Income Tax Rate Reconciliation, Tax Settlement, Amount 3 month | Effective Income Tax Rate Reconciliation, Tax Settlement, Amount 3 month as first filed | Effective Income Tax Rate Reconciliation, Tax Settlement, Amount 6 month | Effective Income Tax Rate Reconciliation, Tax Settlement, Amount 9 month | Effective Income Tax Rate Reconciliation, Tax Settlement, Amount 12 month |
|---|---|---|---|---|---|
| 2024-12-31 | $162.00M 10-K · filed 2025-02-12 | ||||
| 2023-12-31 | $162.00M 10-K · filed 2024-02-14 | ||||
| 2022-12-31 | $324.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | $162.00M derived: sum of 2 quarters · filed 2023-11-03 | $162.00M 10-K · filed 2023-02-10 | ||
| 2022-09-30 | -$162.00M 10-Q · filed 2023-11-03 | $162.00M 10-Q · filed 2022-11-01 | -$162.00M 10-Q · filed 2023-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |